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The ideal vaccine not only protects the immunized host against clinical dis- 
ease but also interrupts the chain of transmission of the pathogenetic organism, 
thereby protecting the nonlmmunized members of the population. In the in- 
stance of a disease which is spread primarily by contact with a clinical case, a 
vaccine, if effective, will perform both functions. However, in order to decrease 
the rate of transmission of a disease which is spread primarily by the asympto- 
marie carrier,  a vaccine must be able to interfere with the carrier state. This 
effect has been shown for several irnmunlz~ng  agents and may be correlated with 
the presence of secretory antibodies (1--6). A relevant example is the study of 
MacLeod et al. (7) showing that vaccination with purified pneumococcal poly- 
saccharides not only prevents lobar pneumonia, but also results in a significant 
lowering of the carrier rate among the immunized population. 
The preceding studies have shown that the group A and the group C menin- 
goeoccal polysaccharides,  if prepared in a high molecular weight form (8) are 
excellent immunogens in humans (9). It has also been shown that antibodies to 
the group C polysaccharide play a major role in naturally acquired immunity  to 
meningococcal disease (10). There is reason, therefore, to hope that antibodies 
artificially induced with the purified  polysaccharides  will perform the same 
protective function as the ones produced as a result of the carrier state (11). 
However, it remains to be determined whether this immunization also will give 
rise to local immunity in the nasopharynx, and hence be of value in controlling 
the transmission of meningococcal disease. Towards this end, a small-scale field 
trial was carried out in military recruits to test the effect of immunization with 
meningococcal C polysaccharide upon the acquisition of group C meningococci. 
Materials  and Methods 
Design of the E.~peffment.--The experiment to test whether immunization  with the C 
antigen would prevent the acquisition  of group C meningococci  was initiated  in three basic 
training companies at Fort Dix, N. J., at the end of April 1968. The recruits had been on 
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the military base for 9  or 10 days at  the time the first nasopharyngeal culture and serum 
specimen were obtained. The purpose of the study and the nature of the vaccines were ex- 
plained  and  the written consent of  each  volunteer was  obtained.  50  men from  Company 
B-6-3 and 50 from Company E-2-3 were selected at random from a greater number of volun- 
teers  and  vaccinated with  the  C  antigen.  53  additional volunteers were  injected with  A 
polysaccharide. Only 45 men in Company E-5-3 volunteered and all were injected with the 
C antigen. The numbers of immunized recruits and controls are shown in Table I. 
All available recruits in the vaccinated and control groups were cultured 2, 4, and 6 wk 
after immunization; serum was obtained at 2 and 6 wk.  In the course of  the study,  5.9% 
of the population was lost to follow-up for various reasons. 
Serological MeZtwds.--Sera were stored in the frozen state.  Recruits in Companies E-5-3 
and E-2-3 were bled 12 days after immunization, whereas Company B-6-3 was bled at 14 days. 
These  sera will be referred to  as  the 2nd wk  sera.  Passive hemagglutination with human 
erythrocytes sensitized with the C  antigen was performed as described before (8). However, 
glutaraldehyde-fixed  cells  sensitized with  A  antigen  (8)  were  found  to  be  nouspecifically 
TABLE  I 
Distribution  of  Re~rui~s Injecled  with  Group A  or Group C  Meningococcal Polysaccharide 
Company 
B-6-3 
E-5-3 
E-2-3 
total. 
Number immunized  with 
A alltJgell 
17 
0 
36 
53 
C antigen 
50 
45 
50 
Controls 
181 
185 
117 
483 
Total 
248 
230 
203 
581 
agglutinated by these frozen and thawed sera. This did not occur when fresh ,mfi~ed red blood 
cells were sensitized with the A  antigen. The donor of the fresh ceils was the same person 
from whom the aldehyde-fixed cells were obtained. 
Antibody was also measured by the bactericidal reaction as described previously (11). 
Bac~erlological Me~ds.--Nasopharyngeal cultures were performed as described by Arten- 
stein et al. (12)  except that chocolate Mueller-Hinton agar (13) was used. Meningococci were 
identified by colonial appearance,  examination of a  Gram-stained smear and carbohydrate 
fermentations. The serological grouping was performed both by the slide agglutination method 
with hyperimmune rabbit sera (14), and by the hemagglutination inhibition method described 
previously (8). In the occasional instance of disagreement between the two procedures,  the 
results obtained with the hemagglutinatlon inhibition test were accepted. 
Immunizalion.--Recrnits were injected intradermally with 0,2 ml of isotonic saline con- 
raining 50/.tg of either group A polysaceharide lot A-5 or group C polysaccharide lot C-5 (8). 
Skin reactions were measured by a single observer at 24 and 48 hr after immunization. Each 
injected volunteer was questioned concerning systemic symptoms. 
Statistical Metkods.--The chi square (X  ~) method was used to evaluate the differences in 
carrier or acquisition rates of the different populations. The t test with the correction for small 
samples was used to test the differences in geometric means of reciprocal hemagglutination 
titers. All calculations were done on the logarithms of the titers (13). GOTSCHLICH,  GOLDSCHNEIDER,  AND  ARTENSTEIN  1387 
RESULTS 
The Epidemiological Setting.--A very high incidence of meningococcemia and 
meningitis, all attributable to group C organisms, occurred in the winter and 
spring of 1968 among recruits undergoing basic infantry training at Fort Dix, 
N. J. Consequently, the incidence of meningococcal carriers  among these re- 
cruits was studied. Two companies in basic training were followed with throat 
cultures from February 13  to April  2. The results are presented in Table II 
which shows the per cent of the population which carried group C meningococci, 
the per cent which  carried  meningococci other than group C, and the total 
carrier rate. A sample of 50 men from each company of 200 men was followed. 
TABLE  II 
Prevalence of Group C and Other than Group C Meningococci in Two Basic Training Companies 
Company 
B-1-3 
D-2-3 
Week of trA~n~n~ 
1 st 
3rd 
8th 
1st 
3rd 
8th 
Group C 
6 
48 
75 
10 
,50 
76 
Per Cent of oalttmm positive 
Not group C 
25 
22 
11 
14 
8 
14 
Total 
31 
70 
86 
24 
58 
90 
There was a rapid spread of group C organisms among the recruits, so that the 
final cumulative rate (the percentage of recruits carrying group C meningococci 
at any time during the period of observation)  was 82 % in Company D-2-3, and 
75 % in B-1-3. These levels for the meningococcal carrier rates were not unusual 
for a military population during the winter months. However,  the preponder- 
ance of group C organisms was a situation not observed heretofore.  This epi- 
demiological setting provided the opportunity to test whether immunization 
with the C antigen would prevent the acquisition  of group C meningococci in 
the nasopharynx. 
The Antibody Response to Immunization with A  and C Antigens.--145 recruits 
were injected intradermally  in the forearm with group C polysaccharide and 53 
with group A polysaccharide. By 24 hr every vaccinated subject had a skin reac- 
tion consisting of an area of erythema varying from 2 to 7 cm in diameter. These 
sites were usually slightly tender and occasionally edematous. In general the 
reactions elicited by the A antigen were less pronounced than the ones resulting 
from the C antigen. None of the recruits reported any systemic symptoms. The 1388  rM-MUNITY  TO  MENINGOCOCCUS.  V 
reactions faded over the next 24  hr and at 2 wk only a small area of pigmenta- 
tion remained in a few individuals. 
Antibody production was measured by assaying the hemagglutinating and 
bactericidal activity of the 2nd wk sera. The sera of two of the members of the 
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FIO.  1.  The  distribution  of  the hemagglutination  titers of  sera  obtained  from  recruits 
immunized with group A  polysaccharide. 
A vaccinated group were not available. Interpretation of the hemagglufination 
response to the injection of the A antigen was not complicated by responses to 
the carrier state, since no group A  organisms were found among the recruits. 
The histogram in Fig. 1 indicates the distribution of the reciprocal hemaggluti- 
nation titers observed. The geometric mean was 182, which should be compared 
to the geometric mean of 7.4 of the titers observed on the preimmunization 
bleeding. This latter figure is included only to illustrate the magnitude of the 
average rise in titer and should not be construed as an indication that the first 
bleedings did or did not contain antibodies to A substance. GOTSCHLICH, GOLDSCHNEIDER~ AND  ARTENSTEIN  1389 
Data on the bactericidal activity of sera obtained two weeks after immuniza- 
tion with A polysaccharide are more difRcult to interpret. 25 of the 51 available 
recipients of A substance were carriers of meningococci at the time the 2nd wk 
sera were obtained. All these sera had a titer of 1/64 or greater against strain 
A1. However, it has been shown that the majority of these individuals would be 
expected to show increased bactericidal activity against group A meningococci 
as a consequence of their carrier state (10). Of the 26 recruits who did not be- 
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FIG. 2. The distribution of the hemagglutination fiters of sera obtained from recruits 
immunized with group C polysaccharide. 
come meningococcal carriers within the first 2 wk of the study, all but two 
showed significant increases in serum bactericidal activity to meningococci of 
strain A1. In this group, reciprocal bactericidal titers of the preimmunization 
sera were 16 or less, those of the 2nd wk sera 64 or more. The two men who 
showed no significant increase in bactericidal titer also had the lowest hemag- 
glutination titers. They should probably be considered immunization failures. 
To obviate problems in the interpretation of the antibody response to the 
injection with group C polysaccharide, all immunized recruits who carried group 
C meningococci at the beginning of the experiment, or acquired them within the 1390  IMMUNITY  TO MENINGOCOCCUS.  V 
first 2 wk of the study, were  excluded from this part of the analysis.  This 
amounted to 11 men, or 7.6% of the population of 144. One vaccinated recruit 
was lost within the 1st wk of the study due to a preexisting  medical problem. 
Fig. 2 shows the distribution of the reciprocal hemagglutination  fiters observed. 
The geometric mean of the titers of the preimmunization bleedings was 1.0; that 
of the 2nd wk sera was 82. 
46 of the 133 recruits immunized with C antigen were carriers of meningococci 
other than group C during the first 2 wk of the study. Although all these in- 
dividuals developed  a  reciprocal  bactericidal  fiter of 64  or greater against a 
group C organism, strain Cll, it cannot be stated whether this was in response 
to the vaccination or to the carrier  state (10). The remaining 87 vaccinated 
recruits who were not meningococcal carriers during the first 2 wk of the study 
all developed bactericidal activity against strain Cll, with reciprocal titers of 
64 (4 men) or more (83 men). The preimmunization reciprocal titers were 16 
or less. 
The bactericidal  and hemagglutination data indicate that all the recruits in 
the population of 133 who did not carry group C meningococci during the first 
2 wk of the study reacted positively to immunization with C polysaccharide. 
There is no unequivocal method to decide whether the 11 recruits in the C-vac- 
cinated group who were carders of group C meningococci during the first 2 wk 
of the study responded  to the vaccine or to the carrier  state. In either event, 
hemagglutination and bactericidal  titers were elevated in each member of this 
group. 
Effect of the Injection of Group-Specific Polysacckarides upon the Acquisition oJ 
Meningococci in the Nasopkarynx.--There  was considerable variability in the 
prevalence of menlngococci of various serogroups between the three basic train- 
ing companies. Therefore, each company  was considered separately in evaluating 
the cultural data. The results are set forth in Table III, showing the menin- 
gococcal carrier rates observed among the various experimental  groups. Com- 
pany E-2-3 had the most rapid spread of group C organisms among its members. 
Initially, the C carder rates were low in all companies and evenly distributed 
among the C-vaccinated, A-vaccinated,  and uninjected groups. But by the 2nd 
wk and at all times thereafter the group injected with C antigen had a lower C 
carrier rate than did the control group. These differences were in most instances 
statistically significant as indicated in the table. In addition, the prevalence for 
all types of meningococci tended to be lower in the group vaccinated with C 
antigen, whereas the prevalence of meningococci other than group C tended to 
be higher. This suggested that the depression of the total carrier rate due to the 
lower prevalence of group C organisms among the recruits vaccinated with the 
C antigen was partially offset by an increased prevalence of meningococci not 
belonging to group C. There was considerable variability in the prevalence of 
meningococci in the A immunized group in Company B-6-3 which was probably GOTSCHLICH~ GOLDSCHNEIDER,  AND ARTENSTEIN  1391 
due to the small size of that population. Nevertheless, from the results obtained 
both in Company B-6-3 and in Company E-2-3, it is dear that immunization 
with the A antigen did not lower the C carrier rate. 
The results were also treated in terms of the cumulative acquisition rate of 
group C meuingococci, since this allows a summary of the data over the whole 
6 wk period of observation. Table IV presents the percentage of men in each 
population who acquired group C  meningococci in the 6  wk period following 
TABLE IH 
Prevalence of Meningococci in tke Nasopkaryages of Recruits Immunized u,  itk A  Anligen, 
C Antigen, and of Controls 
Per cent of cultures positive 
2nd culture  3rd culture  4th culture  t~mny 
Co. B-6-3 
Controls 
A vacc. 
C vacc. 
Co. E-5-3 
Controls 
C vacc. 
Co. E-2-3 
Controls 
A vacc. 
C vacc. 
1st culture 
G~up  Not  g~p  Total 
2.7  20  23 
0.0  47  47 
6.0  24  30 
0.54  5.4  5.9 
2.2  4.4  6.6 
5.1  20  25 
2.7  8.3  11 
4.0  28  32 
11 
5.9 
2.0" 
3.4 
2.2 
30 
36 
tot 
Not 
g~P 
23 
18 
26 
29 
23 
17 
28 
Total  G~oup 
34  23 
24  29 
24  8.7* 
30  19 
31  4.5* 
53 
53 
38  24t 
Not 
group Total 
36  59 
57  86 
37  46 
29  48 
45*  50 
23  73 
20  71 
28  52t 
[Notl  i Gr~  up  group ] Total 
.... 
28  28  56 
24  47  71 
17  35  52 
29  21  49 
7.0t  35  42 
43  18  61 
39  14  53 
14§  27  41" 
The percentages with footnote symbols are significantly different from the control group. 
* P  <  0.05. 
t P  < O.Ol. 
§ P  <  o.ool. 
immunization with the polysaccharides. During the period of this study, a con- 
siderably lower percentage of recruits immunized with the C antigen acquired 
group C meningococci than did either the men injected with A  antigen or the 
unlnjected  controls.  The differences between the uninjected  groups and  the 
C-vaccinated groups were statistically highly significant. 
The Relationship between Serum Antibody and the Acquisition of the Meningo- 
coccal Carrier State.--The serum antibody response to immunization with  C 
antigen was measured by passive hemagglutination on 133 sera obtained 2 wk 
after injection with the C polysaccharide. As stated in a previous section, the 1392  ~Y  TO MENINGOCOCCUS.  V 
mean reciprocal titer rose from 1.0 to 82. None of these recruits carried group C 
meningococci in the 2 wk period preceding this bleeding, but 22 of them acquired 
group C organisms in the subsequent 4 wk of the study. 
In order to determine whether there is a  positive  correlation  between the 
serum antibody response and local nasopharyngeal defenses against the menin- 
gococcal carrier state, the mean of the reciprocal hemagglutination titers of the 
2nd wk bleedings of the 22 vaccinated subjects who became C carriers,  and of 
those who did not, was calculated separately and compared,  using the t test. 
The mean of the first group was 47 and of the second group 91. The difference 
between these means is statistically significant (P =  0.001). 
TABLE  IV 
Per Cent of Recruits in Each Group who became Carriers of Group C Meningo¢oeci 
Company  Controls  A-vaccinated  C-vacclnated 
%  %  % 
B-6-3  42  37  24* 
E-5-3  38  --  4.6§ 
E-2-3  69  68  31 § 
The percentages  with  footnote  symbols  differ  significantly  from  the control  group. 
* P  <  0.05. 
§ P  <  o.ool. 
DISCUSSION 
The studies reported in the present series have indicated that the suscepti- 
bility of the human being who develops meningococcal disease is due, at least 
in part, to the lack of circulating antibodies to the particular strain of meningo- 
coccus with which he becomes infected (11). The natural immunity which the 
majority of the adult population enjoys probably depends on repeated naso- 
pharyngeal contact with the meningococcus. The carrier state has been shown 
clearly to be an immunizing process which gives rise to antibodies to several 
meningococcal antigens,  among them the group-specific polysaccharides  (10). 
The interest of the latter antigens is that they have been partially defined im- 
munochemically  and that a method has been developed for producing them in 
large molecular weight form and high purity (8). They have proved to be good 
immunogens in humans giving rise to antibodies belonging to the three major 
classes of immunogiobulins. The sera of the injected volunteers became highly 
bactericidal  to all meningococci belonging to the group represented  in the vac- 
cine. This response  has remained essentially undiminished for as  long  as 8 
months (9). This is in keeping with the studies showing that, in man, theprecipi- 
taring antibody response to pneumococcal polysaccharides  persists for at least 
3 yr and the demonstration that the bactericidal activity against meningococci 
is mediated by antibodies belonging to the immunoglobulin G class (16, 9). GOTSCHLICH~ GOLDSCHNEIDER, AND AETENSTEIN  1393 
It should be noted that the mean hemagglutination response of the recruits 
to these antigens was less than that of six laboratory volunteers (9). The ex- 
planation for this is unknown. One factor which should be considered in future 
studies is that the recruit population may have experienced the phenomenon of 
antigenic competition, as they had all their routine immunizations immediately 
preceding the injection with polysaccharide (17, 18). 
The present report has delineated another desirable property of the group C 
polysaccharide when used as an immunogen in a population with a high menin- 
gococcal transmission rate. It has shown that  systemic immunization with this 
material  gives  rise  to  increased  local  defenses in  the  nasopharynx  against 
meningococci,  as evidenced by the fact that a significantly  lower percentage of 
vaccinated recruits became carriers  of group C meningococci when compared to 
the control group. This difference applies only to organisms belonging to group 
C. The specificity of this local immunity suggests that a recognition mechanism 
is involved, and it seems plausible that secretory immunoglobulin A antibody 
accomplishes  this function. Studies are in progress to determine whether im- 
munization with the meningococcal  polysaccharide gives rise to the production 
of secretory antibody. Whether other mechanisms are involved in making the 
nasopharyngeal environment unsuitable for the group C meningococci  is un- 
known. One possibility is that there is a selective pressure causing the group C 
meningococcus rapidly to lose the property of making the C  antigen.  These 
organisms  would then  be untypable,  This  hypothesis was tested  by seeing 
whether the proportion of untypable meningococci  among the organisms iso- 
lated was significantly higher in the group vaccinated with the C antigen. No 
significant differences were noted, indicating that this hypothesis is not tenable. 
An intriguing sidelight of these studies was the observation that there is a cor- 
relation between the degree of serum immunity as measured by passive hemag- 
glutination and the degree of local nasopharyngeal resistance to the acquisition 
of group  C meningococci.  Such a  correlation  has been noted previously for 
poliovirus (2),  rhinovirus (19),  and streptococci; in the latter instance, it has 
been shown that preexisting antibody to the M protein markedly lowered the 
rate of throat infection with streptococci of the homologous type (20). 
Four recruits from the companies studied developed meningitis.  These in- 
dividuals had not been vaccinated with either polysaccharide. Because of the 
relatively small size of this study, no significance can be attached to this occur- 
rence.  Much larger field trials will be required to determine whether adminis- 
tration of these antigens prevents meningococcal  disease.  Hospitalizations for 
other illnesses (mainly acute respiratory disease) were also monitored and these 
were equally common in the immunized and unlnjected recruits. 
Group A meningococci at the present time are very rarely isolated in the 
United States, and it was impossible to determine whether immunization with 
this polysaccharide would interfere with the acquisition of group A meningo- 
cocci. This important information should be obtained as soon as possible by a 1394  ~UNITY  TO MENINGOCOCCUS. V 
field trial in a location where there is a high prevalence of group A strains. This 
knowledge would be helpful in the planning of a field trial to test the effective- 
ness of these polysaccharides as vaccines for the prevention of meningococcal 
disease. The success of such studies might be jeopardized by immunizing too 
large a proportion of the population, as it seems likely that this measure would 
effectively  diminish the transmission of meningococci in the control populations. 
There is, in fact, evidence that just such a phenomenon occurred in the study 
by MacLeod et al. (7) where half the population was vaccinated with pneumo- 
coccal polysaccharides. It should also be borne in mind that the group A menin- 
gococcus has  been  responsible  for the  majority of  epidemic meningococcal 
disease, and now that sulfonamide-resistant strains have been isolated overseas 
(21), this organism again represents a major public health hazard. 
SUX~&R¥ 
Purified meningococcal polysaccharides were administered to army recruits. 
No adverse reactions were observed in 145 men who received group C polysac- 
charide, and in 53 men who were injected with group A polysaccharide. Hemag- 
glutinating and bactericidal activity developed in the sera of all individuals 
with the exception of two recruits injected with A polysaccharide. 
During the 6 wk period of observation, the proportion of unvaccinated re- 
cruits who acquired group C meningococci in the three companies studied was 
38, 42, and 69 per cent. A significantly lower proportion of the individuals vac- 
cinated with group C polysaccharide acquired group C meningococci; 4.6, 24, 
and 31 per cent respectively. 
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